Patent Assignment
Reel/Frame 019658/0176
Release of Security Interest (Reel/Frame 018746/0676)
Recorded: 2007-08-07
Pages: 9
Assignor
BAKER BROS ADVISORS, LLC
Executed: 2007-07-25
Assignee
SYNVISTA THERAPEUTICS, INC.
165 LUDLOW AVENUE, NORTHVALE, NEW JERSEY, 07647
Covered Properties
(104)
2-(2-Furoyl)-4(5)-28FURANYL)-Ih-Imidazole
Patent:
4,665,192 →
Application:
06/590,820 →
Method and Agents for Inhibiting Protein Aging
Patent:
4,758,583 →
Application:
06/798,032 →
Method and Agents for Removing Advanced Glycosylation Endproducts
Patent:
4,900,747 →
Application:
07/091,534 →
Inhibitors of Nonenzymatic Cross-Linking
Patent:
4,908,446 →
Application:
07/119,958 →
Inhibitors of Nonenzymatic Cross-Linking
Patent:
4,983,604 →
Application:
07/264,930 →
Method and Agents for Inhibiting Protein Aging
Patent:
5,128,360 →
Application:
07/481,869 →
Inhibitors of the Advanced Glycosylation of Proteins and Methods of Use Therefor
Patent:
5,175,192 →
Application:
07/503,804 →
Biguanides and Derivatives Thereof as Inhibitors of Advanced Glycosylation of a Target Protein
Patent:
5,100,919 →
Application:
07/606,425 →
Amino-Substituted Pyrimidines, Derivatives and Methods of Use Therefor
Patent:
5,114,943 →
Application:
07/640,271 →
2-Substituted-2-Imidazolines
Patent:
5,258,381 →
Application:
07/652,575 →
Inhibitors of the Advanced Glycosylation of Proteins and Methods of Use Therefor
Patent:
5,218,001 →
Application:
07/672,946 →
2-Alkylidene-Aminoguanidines and Methods of Use Therefor
Patent:
5,130,324 →
Application:
07/697,212 →
Amidrazones and Derivatives Thereof
Patent:
5,130,337 →
Application:
07/697,213 →
Liver-Derived Receptors for Advanced Glycosylation Endproducts and Uses Thereof
Patent:
5,585,344 →
Application:
07/749,438 →
Mesangial Cell-Derived Receptors for Advanced Glycosylation Endproducts and Uses Thereof
Patent:
5,202,424 →
Application:
07/749,444 →
Method and Agents for Inhibiting Protein Aging
Patent:
5,238,963 →
Application:
07/805,200 →
Compositions Containing Biguanides and Derivatives Thereof as Inhibitors of Nonenzymatic Cross-Linking
Patent:
5,254,593 →
Application:
07/807,609 →
Amino Acids Useful as Inhibitors of the Advanced Glycosylation of Proteins
Patent:
5,334,617 →
Application:
07/825,598 →
1,4 Piperizino Inhibitors of Non-Enzymatic Cross-Linking of Proteeins
Patent:
5,356,895 →
Application:
07/889,141 →
2-Alkylidene-Aminoguanidines and Methods of Use Therefor
Patent:
5,243,071 →
Application:
07/890,556 →
1,2,4-Triazine Products Resulting from the Inhibition of Advanced Gly- Cosylation
Patent:
5,399,560 →
Application:
07/956,722 →
Immunochemical Detection of in Vivo Advanced Glycosylation Endproducts
Patent:
5,624,804 →
Application:
07/956,849 →
Inhibition of the Advanced Glycosylation of Proteins Using Substituted-1,2,4-Triazoles
Patent:
5,318,982 →
Application:
07/986,661 →
Method for Inhibiting Advanced Glycosylation of Proteins Using Aminosubstituted Imidazoles
Patent:
5,358,960 →
Application:
07/986,662 →
Method of Inhibiting the Advanced Glycosylation of Proteins Using 1,2- Disibstituted-Benzimidazloes
Patent:
5,326,779 →
Application:
07/986,673 →
2-Alkylidene-Aminoguanidines and Methods of Use Therefor
Patent:
5,272,165 →
Application:
07/998,539 →
Glycosylation of Lipids and Lipid-Containing Particles, and Diagnostic and Therapeutic Methods and Materials Derived Therefrom
Patent:
5,869,534 →
Application:
08/029,417 →
Methods for Glycosylation Inhibition Using Amino-Benzoic Acids and Derivatives
Patent:
5,476,849 →
Application:
08/162,538 →
Method for Detecting Hemoglobin Advanced Glycosylation Endproducts
Patent:
5,610,076 →
Application:
08/236,416 →
Aminoguanidine Spray Drying Process
Patent:
5,534,551 →
Application:
08/318,754 →
Methods and Materials for the Diagnosis and Treatment of Conditions Such as Stroke
Patent:
5,700,447 →
Application:
08/319,747 →
Monoclonal Antibody for the Detection Advanced Glycosylation Endpro- Ducts in Biological
Patent:
5,744,318 →
Application:
08/367,507 →
Bis-[Hydrazones]
Patent:
5,698,563 →
Application:
08/372,672 →
Preventing and Reversing Advanced Glycosylation Endproducts
Patent:
5,656,261 →
Application:
08/375,155 →
Amino-Benzoic Acids and Derivatives, and Methods of Use
Patent:
5,514,676 →
Application:
08/383,764 →
Methods and Materials for the Diagnosis and Treatment of Conditions Such as Stroke
Patent:
5,801,200 →
Application:
08/418,525 →
Method and Agents for Removing Advanced Glycosylation Endproducts
Patent:
35,465 →
Application:
08/437,064 →
Immunochemical Detection of in Vivo Advanced Glycosylation Endproducts
Patent:
5,712,101 →
Application:
08/472,398 →
Methods and Materials for the Diagnosis and Treatment of Conditions Such as Stroke
Patent:
5,733,933 →
Application:
08/473,009 →
Immunochemical Isolation of in Vivo Advanced Glycosylation Endproducts
Patent:
5,629,408 →
Application:
08/476,381 →
Compositions and Methods for Advanced Glycosylation Endproduct-Mediated Modulation of Amyloidosis
Patent:
6,410,598 →
Application:
08/477,364 →
Antibodies to Liver Derived Receptors for Advanced Glycosylation End- Products and Uses Therefor
Patent:
5,852,174 →
Application:
08/479,149 →
Methods and Materials for the Diagnosis and Treatment of Conditions Such as Stroke
Patent:
5,733,524 →
Application:
08/479,673 →
Therapeutic Methods and Pharmaceutical Compositions
Patent:
5,766,590 →
Application:
08/483,184 →
Monoclonal Antibody Specific for Advanced Glycosylation Endproducts in Biological Samples
Patent:
5,698,197 →
Application:
08/483,186 →
Immunochemical Detection of in Vivo Advanced Glycosylation Endproducts
Patent:
5,733,546 →
Application:
08/484,869 →
Bis-(2-Aryl) Hydrazones
Patent:
5,661,139 →
Application:
08/485,387 →
Methods for Inhibiting the Cross-Linking of Advanced Glycosylation Endproducts
Patent:
5,855,882 →
Application:
08/485,948 →
Antibodies to in Vivo Advanced Glycosylation Endproducts
Patent:
5,702,704 →
Application:
08/486,513 →
Glycosylation of Lipids and Lipid-Containing Particles and Diagnostic and Therapeutic Methods and Materials Derived Therefrom
Patent:
5,780,615 →
Application:
08/486,605 →
Immunochemical Detection of in Vivo Advanced Glycosylation Endproducts
Patent:
5,683,887 →
Application:
08/487,055 →
Methods for Partitioning Advanced Glycosylation Enddproducts
Patent:
5,861,238 →
Application:
08/487,058 →
Method and Agents for Removing Advanced Glycosylation Endproducts
Patent:
5,811,075 →
Application:
08/487,398 →
Compositions and Methods for Stimulating Amyloid Removal in Amyloidogenic Diseases Using Advanced Endproducts
Patent:
5,935,927 →
Application:
08/501,127 →
Monoclonal Antibodies Specific for Advanced Glycosylation Endproducts in Biological Samples
Patent:
5,892,000 →
Application:
08/581,724 →
Preventing and Reversing the Formation of Advanced Glycosylation Endproducts
Patent:
5,853,703 →
Application:
08/588,249 →
Compositions and Devices for Partitioning Advanced Glycosylation Endproducts, and Methods of Their Use
Patent:
5,891,341 →
Application:
08/628,380 →
3-Alkylamino-2-Hydroxy-4-Hydroxymethyl-2-Cyclopenten-1-One Advanced Glycosylation Endproducts and Methods of Use Therefor
Patent:
5,688,653 →
Application:
08/673,217 →
Method and Agents for Inhibiting Protein Aging
Patent:
5,770,571 →
Application:
08/746,742 →
6-(N-Carboxymethylamino)Caproate, Salts Thereof and Methods of Use Therefor
Patent:
5,869,527 →
Application:
08/771,958 →
N-Acylaminoalkyl-Hydrazinecarboximidamides
Patent:
5,877,217 →
Application:
08/771,959 →
Compostions, Including Pharmaeutical Compositions, for Inhibiting the Advanced Glycosylation of Proteins, and Therapeutic Methods Based Thereon
Patent:
5,852,009 →
Application:
08/784,861 →
Triazine Compounds and Methods of Use Therefor
Patent:
5,932,578 →
Application:
08/825,114 →
Preventing and Reversing the Formation of Advanced Glycosylation Endproducts
Patent:
6,007,865 →
Application:
08/971,878 →
Improved Method and Agents for Inhibiting Protein Aging
Patent:
6,025,401 →
Application:
09/062,354 →
Methods for Treatment Predicated on the Presence of Advanced Glycosylation Endproducts in Tobacco and Its Combustion Byproducts
Patent:
6,110,968 →
Application:
09/189,191 →
Reversing Advanced Glycosylation Cross-Links Using Heterocyclic-Substituted Thiazolium Salts
Patent:
6,121,300 →
Application:
09/189,200 →
Triazine Compounds and Methods of Use Therefor
Patent:
6,060,470 →
Application:
09/233,551 →
Preventing and Reversing Advanced Glycosylation Endproducts
Patent:
38,330 →
Application:
09/373,345 →
Glucose and Lipid Lowering Compounds
Patent:
6,326,396 →
Application:
09/439,706 →
Monoclonal Antibody Specific for Advanced Glycosylation Endproducts in Biological Samples
Patent:
39,138 →
Application:
09/465,444 →
Method of Treating Certain Indications Associated with Hyperglycemia
Patent:
6,440,749 →
Application:
09/470,482 →
Triazine compounds and method of use therefor
Patent:
6,380,192 →
Application:
09/552,949 →
Reversing advanced Glycosylation cross-links using Heterocyclic-substituted Thiazolium compounds
Patent:
6,319,934 →
Application:
09/644,024 →
Thiazole, Imidazole and Oxazole Compounds and Treatments of Disorders Associated with Protein Aging
Thiazolium Compounds and Treatments of Disorders Associated with Protein Aging
Synthesis of Thiazolium Compounds
Cyanomethyl Substituted Thiazoliums and Imidazoliums and Treatments of Disorders Associated with Protein Aging
Method for treating fibrotic diseases or other indications IC
Application:
09/905,188 →
Publication:
US 2002/0068729
Method for treating glaucoma IIB
Application:
10/036,856 →
Publication:
US 2002/0119970
Method for Treating Fibrotic Diseases and Other Indications
Method for Treating Glaucoma Ic
Method for Treating Fibrotic Diseases or Other Indications Utilizing Thiazole Oxazole and Imidazole Compounds
Glucose and Lipid Lowering Compounds
Method for Treating Fibrotic Diseases with Azolium Chroman Compounds
Method for Treating Glaucoma V
Method for Treating Glaucoma Vi
Reversing Advanced Glycosylation Cross-Links Using Heterocyclic-Substituted Thiazolium Compounds
Preventing and Reversing the Formation of Advance Glycosylation Endproducts
Method for Treating Fibrotic Diseases or Other Indications Utilizing Thiazole, Oxazole and Imidazole Compounds
Sunscreen Compositions and Methods of Use Thereof
Sunscreen Compositions and Methods of Use Thereof
Substituted imidazoliums and methods of use therefor
Application:
10/828,051 →
Publication:
US 2004/0198795
Method for Treating Fibrotic Diseases or Other Indications Utilizing Thiazole, Oxazole and Imidazole Compounds
Method for treating fibrotic diseases or other indications IE
Application:
10/873,056 →
Publication:
US 2004/0235837
Thiazole, imidazole and oxazole compounds and treatments of disorders associated with protein aging
Application:
11/204,231 →
Publication:
US 2006/0014781
Method for treating glaucoma III B
Application:
11/295,213 →
Publication:
US 2006/0287318
Method for treating glaucoma IV B
Application:
11/296,544 →
Publication:
US 2006/0281749
Method of treating fibrotic diseases or other indications with imidazolium agents
Application:
11/351,390 →
Publication:
US 2007/0043016
Preventing and reversing the formation of advance glycosylation endproducts
Application:
11/351,655 →
Publication:
US 2007/0025926
Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
Application:
11/364,795 →
Dihydrothiazine Prodrugs of Thiazolium Agents
Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging
Application:
11/432,034 →
Publication:
US 2007/0099892
Method for treating glaucoma IIB
Application:
11/482,666 →
Publication:
US 2007/0161616
Related Assignments
(5)
Other recorded transfers of the patents in this record — the chain of ownership.
Intellectual Property Security Agreement
Jan 12, 2007
From: ALTEON INC., A DELAWARE CORPORATION
To: BAKER BROS ADVISORS, LLC, AS COLLATERAL AGENT FOR THE SECURED PARTIES
Reel/Frame 018746/0676 →
Executive Order 9424, Confirmatory License
Feb 8, 2009
From: ROCKEFELLER UNIVERSITY
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 022223/0180 →
Intellectual Property Security Agreement
Mar 2, 2009
From: SYNVISTA THERAPEUTICS, INC.
To: BAKER BROS. ADVISORS, LLC, AS COLLATERAL AGENT
Reel/Frame 022331/0074 →
Strict Foreclosure in Full Satisfaction of Loan Obligations
Nov 20, 2009
From: SYNVISTA THERAPEUTICS, INC.
To: BAKER BROS. ADVISORS LLC, IN ITS CAPACITY AS COLLATERAL AGENT
Reel/Frame 023546/0531 →
Patent Assignment
Dec 1, 2009
From: BAKER BROS. ADVISORS LLC
To: BBDX, INC.
Reel/Frame 023586/0215 →